Logo of Robert Koch InstituteLogo of Robert Koch Institute
Publication Server of Robert Koch Instituteedoc
de|en
Browsing by Subject 
  • edoc-Server Home
  • Browsing by Subject
  • edoc-Server Home
  • Browsing by Subject
JavaScript is disabled for your browser. Some features of this site may not work without it.
All of edoc-ServerCommunity & CollectionTitleAuthorSubject
PublishLoginRegisterHelp
All of edoc-ServerCommunity & CollectionTitleAuthorSubject
PublishLoginRegisterHelp
Browsing by Subject 
  • edoc-Server Home
  • Browsing by Subject
  • edoc-Server Home
  • Browsing by Subject

Browsing by Subject "DARPin"

  • 0-9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

Sort by:

Order:

Results:

Now showing items 1-1 of 1

  • title
  • issue date
  • submit date
  • ascending
  • descending
  • 5
  • 10
  • 20
  • 40
  • 60
  • 80
  • 100
    • 2020-09-12Zeitschriftenartikel
      Designed Ankyrin Repeat Protein (DARPin) to target chimeric antigen receptor (CAR)-redirected T cells towards CD4+ T cells to reduce the latent HIV+ cell reservoir 
      Patasic, Lea; Seifried, Janna; Bezler, Valerie; Kaljanac, Marcell; Schneider, Irene C.; Schmitz, Heike; Tondera, Christiane; Hartmann, Jessica; Hombach, Andreas; Buchholz, Christian J.; Abken, Hinrich; König, Renate; Cichutek, Klaus
      Chimeric Antigen Receptor (CAR)-redirected T cells show great efficacy in the patient-specific therapy of hematologic malignancies. Here, we demonstrate that a DARPin with specificity for CD4 specifically redirects and ...
      Terms of Use Imprint Policy Data Privacy Statement Contact

      The Robert Koch Institute is a Federal Institute

      within the portfolio of the Federal Ministry of Health

      © Robert Koch Institute

      All rights reserved unless explicitly granted.